Vimarsana
Biggest News Aggregation in the World

Page 2 - Impacts Questionnaire News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Impacts Questionnaire. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Impacts Questionnaire Today - Breaking & Trending Today

Idorsia Pharmaceuticals Ltd: Swissmedic approves QUVIVIQ (daridorexant) - a first-in-class treatment for chronic insomnia disorder to improve both nighttime symptoms and daytime functioning - Vimarsana News

Idorsia Pharmaceuticals Ltd: Swissmedic approves QUVIVIQ (daridorexant) - a first-in-class treatment for chronic insomnia disorder to improve both nighttime symptoms and daytime functioning

QUVIVIQ is indicated for the treatment of adult patients with insomnia characterized by symptoms present for at least three months and considerable impact on daytime functioningQUVIVIQ, Switzerland's first

Simcere and Idorsia enter into a licensing agreement for daridorexant in China - Vimarsana News

Simcere and Idorsia enter into a licensing agreement for daridorexant in China

/PRNewswire/ -- Simcere Pharmaceutical Group Ltd (2096.HK, "Simcere"), an innovation and R&D-driven pharmaceutical company,and Idorsia Ltd (SIX: IDIA,...

Idorsia Pharmaceuticals Ltd: Idorsia and Simcere enter into a licensing agreement for daridorexant in China - Vimarsana News

Idorsia Pharmaceuticals Ltd: Idorsia and Simcere enter into a licensing agreement for daridorexant in China

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland & Nanjing, China - November 16, 2022 Idorsia Ltd (SIX: IDIA, "Idorsia"), specialized in the discovery, development and

Investegate |Idorsia Pharmaceuticals Ltd Announcements | Idorsia Pharmaceuticals Ltd: Idorsia and Simcere enter into a licensing agreement for daridorexant in China - Vimarsana News

Investegate |Idorsia Pharmaceuticals Ltd Announcements | Idorsia Pharmaceuticals Ltd: Idorsia and Simcere enter into a licensing agreement for daridorexant in China

Investegate announcements from Idorsia Pharmaceuticals Ltd, Idorsia and Simcere enter into a licensing agreement for daridorexant in China

Idorsia Japan announces positive results with daridorexant - Vimarsana News

Idorsia Japan announces positive results with daridorexant

Ad hoc announcement pursuant to Art. 53 LR Daridorexant demonstrated significant improvement in the subjective measures of Total Sleep Time (sTST) and...